Brief: India's Bliss GVS Pharma Sept-Quarter Consol Net Profit Falls
Oct 21 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS :
* SEPT-QUARTER CONSOL NET PROFIT 205.1 MILLION RUPEES VERSUS
309.8
MILLION RUPEES YEAR AGO
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.52 BILLION
RUPEES
VERSUS 2.10 BILLION RUPEES YEAR AGO
Source text: (https://bit.ly/37rGbMp)
Further company coverage: BLIS.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bliss GVS Pharma
See all newsBrief: Bliss GVS Pharma June-Quarter Consol Net Profit 501 Million Rupees
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees